Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Interleukin pathway genotype and the grandiosity dimension of psychosis: a machine learning gene set analysis with unsupervised anomaly detection controls

5 affiliations
  1. 1Department of Neural Engineering and Space Medicine, Institute of Medical Sciences, University of Zielona Góra
  2. 2Jesus College, University of Oxford
  3. 3Space Research Centre, Polish Academy of Sciences
  4. 4Department of Genetics in Psychiatry, Poznań University of Medical Sciences
  5. 5Department of Psychology, Kazimierz Wielki University

Abstract

Immune involvement in psychosis is well supported, although most of the evidence comes from studies of negative and deficit symptoms. Grandiosity, in comparison, has received little attention. It is, however, the one symptom for which the two main accounts of inflammation in psychosis, activation and reward blunting, make opposite predictions. We tested these predictions in 489 patients with schizophrenia from the Poznań cohort, genotyped for 26 functional variants in eight interleukin-pathway genes and rated with the Operational Criteria Checklist (OPCRIT). Grandiosity was scored from the two OPCRIT items for inflated self-esteem and grandiose delusions. The panel was first tested as a whole, and each gene was then analyzed as a set with the sequence kernel association test (SKAT), with false-discovery-rate control and selection-adjusted permutation. For any gene that passed, we localized the signal within it and estimated the effect with Firth penalized logistic regression. Its stability was examined by held-out splits, jackknife, fragility analysis, comparison with five other symptom dimensions, and anomaly detection. The panel as a whole did not predict grandiosity (out-of-fold Spearman rho = 0.041, permutation p = 0.159). One gene, IL10, showed an association (SKAT p = 0.0028, q = 0.023; selection-adjusted p = 0.025), which was confined to the −819/−592 promoter locus. Carriers of two copies had a Firth odds ratio of 5.28 (95% CI 2.37 to 12.48, p = 4.5 × 10 ⁻⁵ ), consistent with a recessive effect, and 65% of the 26 carriers had grandiosity, against 24% of non-carriers. The effect was specific to grandiosity (standardized beta 0.19, p = 2 × 10 ⁻⁵ ) and moderately reproducible across split halves (r = 0.36; mania control r = 0.03). It did not depend on sex, age, or age at onset, and it was unchanged under alternative SKAT kernels, under panel principal components, and after adjustment for neuroleptic response. Two-copy carriage did not differ between the 466 cases and 482 controls. We propose a recessive IL10 −819/−592 effect specific to grandiosity as a hypothesis for independent replication.

Related

  1. Galectins and the Interleukin-33/Suppression of Tumorigenicity-2 Pathway in First-episode Psychosis and Schizophrenia: A Cross-sectional Exploratory Study
    Hüseyin Uçar, Meryem Sebla Ertuğrul, Eda Uçar +2
    Clinical Psychopharmacology and NeurosciencePeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthPMC
  2. Unsupervised anomaly detection for longitudinal comparison in whole-body PET/CT images
    Takahiro Nakao, Shouhei Hanaoka, Yukihiro Nomura +2
    International Journal of Computer Assisted Radiology and SurgeryPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyPMC
  3. Refining E-detectioN Tools for Emerging mental disoRders (ENTER) to identify young people at clinical high risk for psychosis in the community: model development and internal validation
    D. Oliver, P. Fusar-Poli, G. Brunner +22
    medRxivPreprintCC BYFull textPsychiatry & mental healthmedRxiv
  4. Interleukin-6 in acute exercise and training: what is the biological relevance?
    Christian Philip Fischer
    PubMedPeer-reviewedLicence not stated828 citedPhysiologyOpenAlex
  5. Interleukin 6 as a Treatment Target for Depression
    Éimear M. Foley, Nicholas L Turner, Ruta Margelyte +5
    JAMA PsychiatryPeer-reviewedLicence not stated14 citedPsychiatry & mental healthOpenAlex
BibTeX
@article{brzezicki2026interleukin,
  title = {{Interleukin pathway genotype and the grandiosity dimension of psychosis: a machine learning gene set analysis with unsupervised anomaly detection controls}},
  author = {Maksymilian A. Brzezicki and Przemysław T. Zakowicz and Paweł Kapelski and Monika Wilkość-Dębczyńska and Aleksandra Rajewska-Rager and Maria Skibińska},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1936750},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936750/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Interleukin pathway genotype and the grandiosity dimension of psychosis: a machine learning gene set analysis with unsupervised anomaly detection controls
AU  - Maksymilian A. Brzezicki
AU  - Przemysław T. Zakowicz
AU  - Paweł Kapelski
AU  - Monika Wilkość-Dębczyńska
AU  - Aleksandra Rajewska-Rager
AU  - Maria Skibińska
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1936750
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936750/full
AB  - Immune involvement in psychosis is well supported, although most of the evidence comes from studies of negative and deficit symptoms. Grandiosity, in comparison, has received little attention. It is, however, the one symptom for which the two main accounts of inflammation in psychosis, activation and reward blunting, make opposite predictions. We tested these predictions in 489 patients with schizophrenia from the Poznań cohort, genotyped for 26 functional variants in eight interleukin-pathway genes and rated with the Operational Criteria Checklist (OPCRIT). Grandiosity was scored from the two OPCRIT items for inflated self-esteem and grandiose delusions. The panel was first tested as a whole, and each gene was then analyzed as a set with the sequence kernel association test (SKAT), with false-discovery-rate control and selection-adjusted permutation. For any gene that passed, we localized the signal within it and estimated the effect with Firth penalized logistic regression. Its stability was examined by held-out splits, jackknife, fragility analysis, comparison with five other symptom dimensions, and anomaly detection. The panel as a whole did not predict grandiosity (out-of-fold Spearman rho = 0.041, permutation p = 0.159). One gene, IL10, showed an association (SKAT p = 0.0028, q = 0.023; selection-adjusted p = 0.025), which was confined to the −819/−592 promoter locus. Carriers of two copies had a Firth odds ratio of 5.28 (95% CI 2.37 to 12.48, p = 4.5 × 10 ⁻⁵ ), consistent with a recessive effect, and 65% of the 26 carriers had grandiosity, against 24% of non-carriers. The effect was specific to grandiosity (standardized beta 0.19, p = 2 × 10 ⁻⁵ ) and moderately reproducible across split halves (r = 0.36; mania control r = 0.03). It did not depend on sex, age, or age at onset, and it was unchanged under alternative SKAT kernels, under panel principal components, and after adjustment for neuroleptic response. Two-copy carriage did not differ between the 466 cases and 482 controls. We propose a recessive IL10 −819/−592 effect specific to grandiosity as a hypothesis for independent replication.
SN  - 1664-3224
ER  -